You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三葉草(02197.HK)曾反彈32%重越20天線 披露新冠候選疫苗顯示持久保護力
阿思達克 03-18 14:47
三葉草生物-B(02197.HK)披露旗下新冠候選疫苗顯示出持久高度保護力及作為加強針針對Omicron變異株產生增強免疫應答。繼上日(17日)盤中見上市低位5.6元喘穩後,該股今日(18日)終止三連跌,曾一舉重越10天及20天線(7.03元及7.48元),曾急彈近31.6%高見7.9元,現報7.13元,回升18.8%,一向薄弱成交急增至1,628萬股,僅次於去年11月初首掛日成交量。 三葉草公布,多項評估新冠候選疫苗SCB-2019(CpG 1018/鋁佐劑)積極臨床研究結果顯示,SCB-2019在基礎免疫接種後產生持久高保護效力,以及作為加強針接種後針對Omicron變異株產生增強免疫應答,為其作為基礎免疫疫苗和通用候選加強針提供了強有力的證據。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account